Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells ...
Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...
Northwestern Medicine investigators have discovered new mechanisms underlying cellular adhesion and repair, findings that ...
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback